When evaluating synaptic dysfunction biomarkers in CSF, it was demonstrated that SNAP25, 14‐3‐3 zeta/delta, and NPTX2 (neuronal pentraxin), in various combinations, can discriminate AD from other neurodegenerative diseases.50, 51. The gene discussed is NPTX2; the disease is Alzheimer disease.